Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism

Exclusion Criteria

• •Pregnant or lactating women
• •Patients with severe heart, liver and kidney dysfunction
• •Patients with a history of cerebrovascular disease and who still suffered from serious neurological dysfunction that had an influence on the trial
• •Patients with physical disabilities, joint deformities or muscle lesions
• •Patients were confirmed with intracranial hemorrhage by CT
• •Patients were allergic to the study drug
• •Patients suffering from severe systemic infection
• •Patients who had participated in other clinical trials within 1 month
• •For any reason, the researchers believed that the subject was unlikely to complete the study (such as cerebral infarction caused by cerebral embolism, intracranial arteritis, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and moyamoya disease; patients undergoing thrombolysis or thrombectomy after admission; patients and their families were unable to cooperate with follow-up.)